RetinalGenix Technologies Inc. (RTGN): Cash & Equivalents

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$38
As of 2022-12-31
$4.9K2020-12-31: $2.2K2021-12-31: $4.9K2022-12-31: $38$38
2020-12-31 Cash & Equivalents (USD) 2022-12-31
Period endedCash & EquivalentsChange YoYSource filing
2022-12-31$38-99.2%2024-04-01, Balance as of period end
2021-12-31$4.9K+122.9%2023-06-15, Balance as of period end
2020-12-31$2.2Kn/a2022-04-15, Balance as of period end